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The development of the nervous system involves the overproduction of synapses but
connectivity is refined by Hebbian activity-dependent axonal competition. The newborn
skeletal muscle fibers are polyinnervated but, at the end of the competition process,
some days later, become innervated by a single axon. We used quantitative confocal
imaging of the autofluorescent axons from transgenic B6.Cg-Tg (Thy1-YFP)16 Jrs/J
mice to investigate the possible cooperation of the muscarinic autoreceptors (mAChR,
M1-, M2- and M4-subtypes) and the tyrosine kinase B (TrkB) receptor in the control of
axonal elimination after the mice Levator auris longus (LAL) muscle had been exposed
to several selective antagonist of the corresponding receptor pathways in vivo. Our
previous results show that M1, M2 and TrkB signaling individually increase axonal loss
rate around P9. Here we show that although the M1 and TrkB receptors cooperate and
add their respective individual effects to increase axonal elimination rate even more,
the effect of the M2 receptor is largely independent of both M1 and TrkB receptors.
Thus both, cooperative and non-cooperative signaling mechanisms contribute to
developmental synapse elimination.
Keywords: motor nerve terminal, cholinergic synapses, neuromuscular junction, presynaptic muscarinic
acetylcholine receptors, TrkB receptor, synapse elimination
INTRODUCTION
During the development of the nervous system, synapses are eliminated on a broad scale
(Thompson, 1985; Bourgeois and Rakic, 1993). This allows connectivity to be refined on the basis
of Hebbian activity-dependent axonal competition (Jansen and Fladby, 1990; Sanes and Lichtman,
1999). In newborn animals, the skeletal muscle fibers are polyinnervated in the neuromuscular
Abbreviations: AC, adenyl cyclase; ACh, acetylcholine; AR, adenosine receptors; BDNF, Brain-derived neurotrophic
factor; EPP, evoke endplate potentials; IP3, inositol triphosphate; LAL, Levator auris longus muscle; mAChR,
muscarinic acetylcholine receptor; M1, M1-type muscarinic acetylcholine receptor; M2, M2-type muscarinic
acetylcholine receptor; M4, M4-type muscarinic acetylcholine receptor; MET, methoctramine; MT-3, muscarinic
toxin 3; nAChR, nicotinic acetylcholine receptor; NMJ, neuromuscular junction; NT-4, neurotrophin-4; PBS,
phosphate buffered saline; PIR, pirenzepine; PKA, protein kinase A; PKC, protein kinase C; PLC, phospholipase C;
TrkB, tropomyosin-related kinase B receptor; VDCC, voltage-dependent calcium channels.
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junction area (NMJ; Redfern, 1970; Brown et al., 1976; Ribchester
and Barry, 1994), but at the end of the axonal competition,
endplates are innervated by a single axon (Benoit and Changeux,
1975; O’Brien et al., 1978; Jansen and Fladby, 1990; Sanes
and Lichtman, 1999). This peripheral synapse has been studied
extensively as a model for synapse development (Liu et al., 1994;
Nguyen and Lichtman, 1996; Chang and Balice-Gordon, 1997;
Sanes and Lichtman, 1999; Lanuza et al., 2001; Santafé et al., 2001;
Herrera and Zeng, 2003;Wyatt and Balice-Gordon, 2003; Buffelli
et al., 2004; Garcia et al., 2010). Several signaling molecules
and presynaptic receptors play a role in the axonal competition,
which means that the various nerve endings influence one
another (Santafé et al., 2009a; Garcia et al., 2010; Nadal et al.,
2016). Postsynaptic-derived trophic substances (Nadal et al.,
2016) and the participation of glial cells (Lee et al., 2016; Yang
et al., 2016) also make a decisive contribution.
In a previous study, we investigated how individual
muscarinic acetylcholine receptor (mAChR) subtypes (M1,
M2 and M4), adenosine receptors (AR; A1 and A2A) and
tropomyosin-related tyrosine kinase B (TrkB) receptors are
involved in the control of synapse elimination in the mouse
NMJ (Nadal et al., 2016). The data show that mAChR, AR and
TrkB signaling lessen the initial chance of axonal elimination
(around P5–P7) by extending the period of axonal competition
but then increase (around P9) axonal loss rate (Nadal et al.,
2016). The three receptor sets promote axonal disconnection at
the beginning of the second postnatal week largely independently
of the postsynaptic nicotinic acetylcholine receptor (nAChR)
cluster maturation. In addition, a real cooperation between some
of the mAChR and AR subtypes is observed. More specifically,
preliminary results show that both AR subtypes (A1 and A2A)
can add their independent effect on axonal loss to the effect of
the M1 muscarinic receptor, which leads to greater elimination
because of the additive effect of the pathways (Nadal et al.,
2016).
In this study, we investigate whether the mAChR subtypes
and the TrkB receptor also work together, and whether the
respective pathway inhibitors have any additive or occlusive
effects and, therefore, whether there is any real cooperation
between them in synapse elimination at the NMJ. The main
result shows that, like the mAChR and AR relations, the effect
of M1 and TrkB receptors can be added to increase axonal
loss rate at P9 but that the effect of M2 is largely independent
of the TrkB receptors. Thus, cooperative and non-cooperative
signaling contribute to synapse elimination, which highlights the




Transgenic B6.Cg-Tg (Thy1-YFP)16 Jrs/J mice were used (The
Jackson Laboratory,Bar Harbor, ME, USA). The mice express
spectral variants of GFP (yellow-YFP) at high levels in motor and
sensory neurons, and axons are brightly fluorescent all the way to
the terminals.
Experiments were performed on the Levator auris longus
(LAL) muscle. Neonatal pups of either sex (9 days) were
obtained and the date of birth was designated postnatal day
0 (P0). We minimized the variability in our measurements by
carefully monitoring the timing of conception. Also, the weights
of the individuals were within 5% of the mean for a given
day after conception. The mice were cared for in accordance
with the guidelines of the European Community’s Council
Directive of 24 November 1986 (86/609/EEC) for the humane
treatment of laboratory animals. All experiments on animals
have been reviewed and approved by the Animal Research
Committee of the Universitat Rovira i Virgili (Reference number:
0233).
Injection Procedure
The newborn mice were anesthetized with 2% tribromoethanol
(0.15 ml/10 g body weight, i.p.). Mice pups received daily
subcutaneous injections in the back of the neck beginning on
postnatal day 5 of one or two substances (combinations of two
selective mAChR antagonists or of one mAChR antagonist plus
the TrkB signaling agent TrkB-Fc). Under aseptic conditions,
solutions were administered in 50 µl of sterile physiological
saline by subcutaneous injection over the LAL external surface
as described elsewhere (Lanuza et al., 2001). The animals
received four injections from postnatal day 5, and the LAL
muscles were studied on day 9. Control injections were given in
exactly the same way as experimental injections, using phosphate
buffered saline (PBS) alone. No differences were found between
the muscles injected or not with PBS, thus indicating that
the injection procedure did not in itself induce changes in
the overall morphology of the motor endplate and nerve
terminals. The solutions were administered at a concentration
in accordance with the previously reported biological action
of the substance (Santafé et al., 2004, 2015; Garcia et al.,
2010).
Tissue Preparation and Histochemistry
Neonatal pups were given a lethal dose of 2% tribromoethanol.
Their heads were removed and fixed in 4% paraformaldehyde
for 1.5 h. After washing in PBS, LAL muscles were removed
and post-fixed for 45 min. After washing in PBS, Thy1-YFP
LAL muscles were incubated in PBS containing a 1/800 dilution
of 1 µg/ml tetramethylrhodamine conjugated α-bungarotoxin
(α-BTX-TRITC; T1175, Molecular Probes, Eugene, OR, USA)
for 1 h at room temperature. Whole muscles were mounted in
Mowiol with p-phenylenediamide (Sigma).
Confocal Microscopy and Morphological
Analysis
NMJs were analyzed using an inverted Nikon TE-2000
fluorescent microscope (Nikon, Tokyo, Japan) connected to a
standard personal computer that was running image analysis
software (ACT-1, Nikon). The number of axons per endplate
was counted. Because of the difficulty of determining the
exact number of axonal inputs for each nAChR cluster, when
more than two axons converged at the same synaptic site we
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classified the NMJs into three groups only: junctions that were
monoinnervated, doubly innervated, or innervated by three or
more terminal axons. These data enabled us to calculate the
‘‘average number of axonal inputs’’ and the ‘‘percentage of
polyneuronal innervation’’ for all fibers receiving two or more
axons.
Statistical Analysis
All NMJs visible in their entirety were scored, with a minimum
of 100 per muscle. At least six muscles were studied for
each age and condition examined. Fisher’s test was applied to
compare percentages. The criterion for statistical significance
was P < 0.05. The categories were scored and the counting was
performed by a person with no knowledge of the age or treatment
of the animals. The data are presented as mean± SD.
Drugs
Selective M1, M2 and M4 mAChR Antagonists
The stock solutions were pirenzepine (PIR) dihydrochloride
(1071, Tocris Bioscience) 10 mM; methoctramine (MET; M105,
Sigma—Aldrich, St. Louis, MO, USA) 1 mM; muscarinic toxin
3 (MT3; M-140, Alomone Labs) 50 µM. The working solutions
used were PIR (10 µM), MET (1 µM) and MT3 (100 nM).
TrkB Receptor-Related Agent
The following stock solutions were used: recombinant human
trkB/Fc Chimera (trkB-Fc; 688-TK; R&D Systems), 100 µg/ml.
Working solutions were trkB-Fc 5 µg/ml.
RESULTS
mAChR and TrkB Receptors in Axon Loss
Control
Figure 1A shows representative confocal immunofluorescence
images of the autofluorescent axons in singly- and
polyinnervated LAL P9 NMJs from B6.Cg-Tg (Thy1-YFP)
mice (hereafter YFP). When the mAChR subtype-selective
inhibitors PIR (M1 blocker) and MET (M2 blocker), and the
TrkB pathway blocker (a TrkB-Fc chimera) were applied once
a day between P5-P8 on the LAL muscle surface, there was
a notable delay in the transition to monoinnervation on the
NMJ observed at P9 (Nadal et al., 2016). However, the M4
subtype blocker MT3 shows no effect on axonal loss at this
time. Figure 1B shows the effect of these selective blockers in
increasing order of their relative ability to delaymonoinnervation
and maintain a high percentage of synapses innervated by three
or more axons (PBS-P9 = MT3 < TrkB-Fc < PIR < MET).
MET and PIR delayed the three-to-one axon transition whereas
TrkB-Fc delayed the two-to-one transition. Therefore, in normal
conditions without inhibitors, the two receptor sets (mAChR
and TrkB) will contribute to promoting axonal disconnection
at the beginning of the second postnatal week (see also Nadal
et al., 2016). However, the absolute potency of these receptors in
modulating synapse loss cannot be directly compared because
the blocking efficacy of the respective selective inhibitors is not
the same.
Cooperation Between mAChR and TrkB
Receptors
Our experiments were designed to investigate the effect on
axonal loss of simultaneous incubation with two inhibitors (two
antagonists of two different receptors) and reveal the possible
occlusive or additive crosstalk effects between the corresponding
pathways. Figures 1C,D show the effect of the association of the
drugs applied between P5 and P8 and observed at P9. Figure 1C
shows the percentage of NMJs—of singly-, doubly- and triply- (or
more) innervated endplates—after the simultaneous inhibition of
two receptors that, individually, clearly modulate axon loss (see
Figure 1B; all except M4). The associations of the M4 blocker
MT3 (which does not affect axonal elimination by itself) with the
other substances has been represented separately in Figure 1D so
that the data is more understandable. The M4 subtype is shown
to have a complementary role.
The association of the mAChR blockers PIR and MET shows
no additive effect or mutual occlusion in relation to axonal
loss (Figure 1C). However, the association of the M1 and TrkB
pathway inhibitors (PIR plus TrkB-Fc) results in a clear addition
of their respective delaying effects on axonal loss. The percentage
of the monoinnervated NMJ after simultaneous exposure to both
inhibitors is significantly less (25% of single junctions) than after
exposure to only PIR (39%) or only TrkB-Fc (43%). Interestingly,
however, the individual effect of the TrkB-Fc does not add to
the effect of MET and the result of this dual drug incubation
is no different from the effect of MET by itself. The delaying
effect of MET on axon loss is the most potent observed in the
present experiments and is produced independently of the state
of TrkB.
Figure 1B shows that the M4 blocker MT3 by itself has
no effect on axonal loss at P9. Figure 1D shows that if
MT3 is simultaneously applied with the other blockers it reveal
some regulatory or complementary role of M4 on the other
receptors. The presence of MT3 does not change the effect of
PIR although some occlusion of the potent effect of MET is
observed. MET still continues to significantly delay axon loss (the
three-to-one transition), however. Interestingly, the presence of
MT3 potentiates the delaying effect of TrkB-Fc on axonal loss,
which indicates that the respective receptor pathways (M4 and
TrkB) are cooperating.
These data are represented in Figure 1E. The green arrows
of different thicknesses show how effective these receptors are at
accelerating axonal elimination (the thicker they are, the greater
their effect; the inhibitor used is in brackets under the name of
the receptor). The M4 receptor by itself does not affect axonal
elimination at P9 (black arrow). Interestingly, the association of
theM1 and TrkB pathway blockers results in the addition of their
respective delaying effects on axonal loss, which indicates that
the corresponding receptors are cooperating (blue bond between
these receptor pathways). However, the potent effect of the M2
cannot be modified with the simultaneous presence of the M1
or TrkB blockers. It seems that the M4 receptor, which does
not by itself affect axonal elimination, cooperates positively with
M2 (dotted green arrow). Also, M4 produces some occlusion of
the TrkB pathway (red arrow) but does not cooperate with M1
(dotted black arrow).
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FIGURE 1 | The picture in (A) shows representative confocal immunofluorescence images of singly-, dually- and polyinnervated neuromuscular junction area (NMJ)
from P9 YFP mice. Scale bar: 10 µm. The histograms in (B) show the percentage of singly-, doubly- and triply- (or more) innervated NMJs in control (phosphate
buffered saline, PBS treated) and levator auris longus (LAL) muscles treated with the inhibitors considered. We show newly reproduced data of previous results to
facilitate comparison (Nadal et al., 2016). (C) shows the percentage of NMJs after the simultaneous inhibition of two receptors clearly involved in axonal elimination
(those that affect axon loss rate when they are individually blocked (all except M4). The associations of the M4 blocker muscarinic toxin 3 (MT3) with the other
inhibitors are represented in (D). An overall representation of the data illustrating the individual role and cooperation of the muscarinic acetylcholine receptor (mAChR)
and tyrosine kinase B (TrkB) receptors in developmental axonal loss modulation is shown in the diagram in (E). The green arrows show how effective these receptors
are at accelerating axonal elimination (the thicker they are, the greater their effect). The association of the M1 and TrkB blockers results in the addition of their
respective effects (blue bond between these receptors). The M4 receptor, which does not by itself affect axonal elimination (black arrow), cooperates positively with
M2 (dotted green arrow) and produces some occlusion of the TrkB pathway (red arrow) but does not cooperate with M1 (dotted black arrow). All NMJs visible in their
entirety were scored, with a minimum of 100 synapses per muscle. At least six muscles were studied for each age and condition examined. Fisher’s test was applied
to compare percentages. When the corresponding antagonist or combinations of two substances were compared with control PBS, significance symbols are:
∗P < 0.05, ∗∗∗P < 0.005. §P < 0.05, §§P < 0.01, §§§P < 0.005 when the combination of two substances were compared with the first. ‡P < 0.05,
‡‡‡P < 0.005 when the combination of two substances were compared with the second.
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DISCUSSION
The present experiments show evidence of the cooperation
between the presynaptic M1, M2 and M4 mAChR subtypes
and the TrkB signaling to modulate the conditions of the
developmental axonal competition and loss. In a previous study
we found that these receptors (as well as presynaptic AR, A1
and A2A subtypes) separately contribute to accelerate synapse
elimination around P9 in the mouse NMJ (Nadal et al., 2016). It
was thought that the muscarinic autoreceptors of the transmitter
acetylcholine (ACh) may allow direct competitive interaction
between nerve endings through a differential activity-dependent
ACh release. The more active axons may directly punish the less
active ones or reward themselves (Santafé et al., 2009a). However,
an axon that is eliminated at one NMJ may be successful at
another (Tomàs et al., 2011), which suggests that other receptors
and local postsynaptic- (and glial cell) derived factors are
involved. The involvement of the TrkB signaling described may
allow a postsynaptic-derived trophic substance such as Brain-
derived neurotrophic factor (BDNF) or neurotrophin-4 (NT-4)
to make a contribution (Yoshii and Constantine-Paton, 2010).
Interestingly, we observed that both the presynaptic-derived
signal (ACh acting on axonal M1 and M2 mAChRs) and
the TrkB-mediated signal (which may be originated by a
postsynaptic-derived NT) have the same effect: namely, the
acceleration of supernumerary nerve ending elimination. It
seems that the outstanding regulatory resources in the NMJ
synaptogenesis are committed to achieving monoinnervation.
These presynaptic receptors converge in a common intracellular
mechanism and a limited repertoire of effector kinases to
phosphorylate protein targets and bring about structural and
functional changes leading to axon loss. It is well known
that in most cells M1 and TrkB operate by stimulating the
phospholipase C gamma (PLC gamma) and therefore the protein
kinase C (PKC) pathway along with the inositol triphosphate
(IP3) pathway, whereas M2–M4 inhibit the adenyl cyclase (AC)
and protein kinase A (PKA) pathway (Caulfield, 1993; Felder,
1995; Caulfield and Birdsall, 1998; Nathanson, 2000). In all
cases, however, common final changes such as intracellular
calcium oscillations can occur (Santafé et al., 2006; Amaral
and Pozzo-Miller, 2012). Both PKA and PKC activity changes
have been shown to affect pre- and postsynaptic maturation
(Lanuza et al., 2001, 2002). Our present data can be related
with the intracellular coupling of the receptors to these serine
kinases. Though the blocking efficacy of the selective inhibitors
of the muscarinic receptors is not assessed here, M2 increases
the axonal loss rate most with a slight involvement of the M4
receptor but independently of the M1 and TrkB receptors. This
suggests that downregulation of PKA activity through the couple
M2–M4 is a key factor in synapse elimination. Concurrently,
M1 and TrkB also contribute separately to axonal loss, but their
combined action has a potent summed effect similar to the
effect of the M2 receptor. This suggest that activation of the
PLC gamma-PKC pathway through the couple M1-TrkB may
be the other key factor in this process. Thus, a displacement of
the PKA/PKC activity ratio to lower values (inhibition of PKA
and/or stimulation of PKC) in some nerve endings may have a
leading role in synapse elimination. In this context, blockade of
PKC in the newborn LAL muscle produces an initial blockade
of synapse elimination and a subsequent delay (Lanuza et al.,
2002).
In fact, these changes in the kinase activity leading to synapse
elimination must occur at least (but not only) in the weakest
axons during the competitive interactions. The neurotransmitter
release capacity is an important factor in the competing capacity
of the various nerve terminals in a NMJ. During development,
in the polyinnervated NMJ several nerve endings with different
levels of maturation and ACh release capacity get together
and compete. The coupling to neurotransmitter release of the
considered receptors and kinases is not the same in each of
these various endings themselves and in the mature synapses
in the adult (Tomàs et al., 2014). So, how does the specific
coupling to ACh release of receptors and kinases in the weak and
strong axons in competition contribute to axonal loss? As far as
serine kinases are concerned, in the adult motor nerve endings
both PKA and PKC potentiate ACh release when coupled
to neurotransmission (Santafé et al., 2009b). Similarly, the
same potentiation is observed in most neuromuscular synapses
during development as, for instance, in those formed by the
strongest axons (those that evoke the large endplate potential,
EPP) in the polyinnervated junctions (Santafé et al., 2004).
However, in the weakest endings the inhibition of PKC increases
the evoked EPP size indicating that, in normal conditions
without any inhibition, this kinase tonically couples to ACh
release reduction in these low releasing synapses. Therefore,
an M1-TrkB-mediated increase in PKC activity in the weakest
endings would debilitate further their ACh release capacity and
competitive force and facilitate their elimination. In addition,
an M2-mediated PKA downregulation in all nerve endings in
competition may differentially affect their ACh release and
contribute to elimination. Thus, at this point, there is a significant
agreement between the known involvement of these molecules in
neurotransmission and axon loss.
However, when considering the real postnatal coupling to
ACh release of the mAChR and the TrkB receptor in the
different nerve endings (the strongest and the weakest) on
developing synapses (Santafé et al., 2004; Garcia et al., 2010),
additional interpretative keys are needed. In the mature NMJ,
M1 and M2 subtypes modulate evoked transmitter release by
positive and negative feedbacks, respectively (Santafé et al., 2003,
2006). However, during NMJ synaptogenesis, the functional
significance of the subtypes is different from in the adult. M2
receptors promote release in all nerve endings independently
of their ACh release level or maturation state whereas an M1-
and M4-mediated reduction in release is observed in the weakest
endings on dual junctions (Santafé et al., 2001, 2002, 2003, 2004,
2007, 2009a). Similarly, the BDNF-TrkB pathway contributes
to potentiate ACh release in different neuromuscular adult
models but the potentiation is not observed in the weakest
nerve endings during development and even some ACh release
inhibition was observed in the strongest endings (Garcia et al.,
2010). Therefore, interpreting the links and molecular relations
between transmitter release and elimination of nerve terminals
seems more complex than it seemed at first. The involvement
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of other signaling such as AR can contribute to this complexity
(Todd and Robitaille, 2006; Nadal et al., 2016). However, some
conclusions can be drawn on the basis of all the above data.
First, it should be pointed out that, contrary to what happens
in the adult, M1 (and M4) and PKC activity reduces ACh
release in the weakest endings and promotes axonal loss. In fact,
blocking mAChRs (M1- and/or M4-subtypes) or PKC or voltage-
dependent calcium channels (VDCCs; P/Q-, N- or L-type or
Ca2+ influx) can lead to similar percentage increases in the
size of the synaptic potentials evoked by weak axons (Santafé
et al., 2003, 2004, 2007, 2009a,b; Tomàs et al., 2011). Therefore,
the M1-PKC pathway may debilitate the ACh release capacity
and competitive force of these synaptic contacts and facilitate
their elimination. The final target molecules involved may be
the VDCC, specially the L-type which is exclusively coupled
to ACh release in these weak endings (Santafé et al., 2001)
and may contribute to carry high calcium near the molecular
mechanism directly involved in axon loss. Second, like M1
signaling, BDNF-TrkB signaling accelerates axon loss. However,
it is not so clear whether it is involved in the modulation
of ACh release in the nerve endings that are in competition
because it does not affect release in the weak axons. Because PKC
effectively reduces release in these endings, the TrkB pathway
may operate through the IP3 pathway to increase intracellular
calcium and modulate the loss of axons. Third, M2 promotes
axonal elimination the most. However, unlike the adult, this
muscarinic subtype promotes ACh release in all the endings
that are in competition, including the weakest endings and the
solitary ending that finally wins the competition. Therefore, there
is a shift in the M2 coupling during development but how this
affects its relation with PKA and how this relates with axonal loss
is not known.
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